Previous Article | Next Article ![]()
J. Virol., 04 1997, 2913-2920, Vol 71, No. 4
Z Chen, RR Rowland, GW Anderson, GA Palmer and PG Plagemann
Neuropathogenic isolates of lactate dehydrogenase-elevating virus (LDV)
differ from nonneuropathogenic isolates in their unique ability to infect
anterior horn neurons of immunosuppressed C58 and AKR mice and cause
paralytic disease (age-dependent poliomyelitis [ADPM]). However, we and
others have found that neuropathogenic LDVs fail to retain their
neuropathogenicity during persistent infections of both ADPM- susceptible
and nonsusceptible mice. On the basis of a segment in open reading frame 2
that differs about 60% between the neuropathogenic LDV- C and the
nonneuropathogenic LDV-P, we have developed a reverse transcription-PCR
assay that distinguishes between the genomes of the two LDVs and detects as
little as 10 50% infectious doses (ID50) of LDV. With this assay, we found
that LDV-P and LDV-C coexist in most available pools of LDV-C and LDV-P.
For example, various plasma pools of 10(9.5) ID50 of LDV-C/ml contained
about 10(5) ID50 of LDV-P/ml. Injection of such an LDV-C pool into mice of
various strains resulted in the rapid displacement in the circulation of
LDV-C by LDV-P as the predominant LDV, but LDV-C also persisted in the mice
at a low level along with LDV-P. We have freed LDV-C of LDV-P by endpoint
dilution (LDV-C-EPD). LDV-C-EPD infected mice as efficiently as did LDV-P,
but its level of viremia during the persistent phase was only 1/10,000 that
observed for LDV-P. LDV-permissive macrophages accumulated and supported
the efficient replication of superinfecting LDV-P. Therefore, although
neuropathogenic LDVs possess the unique ability to infect anterior horn
neurons of ADPM-susceptible mice, they exhibit a reduced ability to
establish a persistent infection in peripheral tissues of mice regardless
of the strain. The specific suppression of LDV-C replication in
persistently infected mice is probably due in part to a more efficient
neutralization of LDV-C than LDV-P by antibodies to the primary envelope
glycoprotein, VP-3P. Both neuropathogenicity and the higher sensitivity to
antibody neutralization correlated with the absence of two of three
N-linked polylactosaminoglycan chains on the ca. 30-amino-acid ectodomain
of VP-3P, which seems to carry the neutralization epitope(s) and forms part
of the virus receptor attachment site.
Copyright © 1997, American Society for Microbiology
Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection
Department of Microbiology, Medical School, University of Minnesota, Minneapolis 55455, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|